Primary Sources: None of the provided documents (e.g., antibody structure analyses , lupus antibody studies , COVID-19 spike antibody research , prion protein investigations , or yeast cell wall studies ) reference "SPAC29A4.23 Antibody."
Databases Checked: The search results focus on immunoglobulins, autoantibodies, and pathogen-specific antibodies but do not include niche or proprietary compounds.
Potential Causes: The antibody may be under development, part of a non-disclosed study, or misidentified in the query.
If data were available, the profile would include:
Structure-Function Analysis: Includes Fab/Fc domain studies and epitope mapping via mutagenesis .
Antigen Binding: Measured using ELISA (e.g., spike protein binding ) or surface plasmon resonance.
Therapeutic Potential: Assessed via in vitro neutralization assays or in vivo models .
Safety: Evaluated for off-target effects and immunogenicity .
SPAC29A4.23 is a protein encoded in the Schizosaccharomyces pombe genome (strain 972 / ATCC 24843), with UniProt accession number P0CU25. Based on the nomenclature, this protein is located on chromosome I of the fission yeast genome. While the specific function of SPAC29A4.23 is not extensively characterized in the available literature, it likely plays a role in cellular processes typical of fission yeast proteins.
For functional characterization, researchers typically employ:
Sequence homology analysis with related proteins
Phenotypic assessment of deletion mutants
Protein localization studies using tagged constructs
Expression profiling under different conditions
Interaction studies to identify binding partners
Understanding the biological context of SPAC29A4.23 is crucial for designing appropriate experimental controls and interpreting antibody-based detection results accurately.
SPAC29A4.23 Antibody can be employed across multiple experimental techniques commonly used in yeast research:
| Application | Typical Protocol Elements | Expected Outcomes |
|---|---|---|
| Western Blotting | Protein extraction using cell lysis, SDS-PAGE separation, transfer to membrane, antibody probing | Detection of SPAC29A4.23 at expected molecular weight |
| Immunofluorescence | Methanol fixation, antibody staining, fluorescent secondary detection | Subcellular localization pattern |
| Immunoprecipitation | Cell lysis under native conditions, antibody incubation, protein capture | Isolation of SPAC29A4.23 and interacting partners |
| Immunogold EM | Sample fixation, sectioning, antibody labeling with gold particles | High-resolution localization in cellular structures |
For each application, optimization of antibody concentration, incubation conditions, and detection methods will be necessary to achieve reliable results .
Successful immunolocalization in S. pombe requires careful consideration of several methodological aspects:
Methanol fixation is particularly effective for preserving S. pombe cellular structures
Cell wall digestion may be necessary for improved antibody penetration
Spheroplasting protocols can enhance accessibility to intracellular antigens
Begin with 1:100 to 1:500 antibody dilutions for optimization
Incubate primary antibody (SPAC29A4.23) for 2-16 hours at 4°C
Use appropriate blocking solution (typically 1-5% BSA) to reduce background
Include 0.1% Triton X-100 or similar detergent for permeabilization if needed
Combine with DAPI staining (1 μg/ml) for nuclear visualization
Consider co-staining with cell wall markers (e.g., Aniline blue for β-1,3-glucan)
Use appropriate filters compatible with secondary antibody fluorophores
For quantitative analysis, maintain consistent exposure settings and acquisition parameters across experimental and control samples .
Rigorous validation is essential to ensure experimental reliability:
Test antibody reactivity in wild-type versus SPAC29A4.23 deletion strains
Compare with strains expressing tagged versions (e.g., SPAC29A4.23-GFP)
Examine cross-reactivity with closely related proteins
Peptide competition assays using the immunizing peptide
Western blot analysis to confirm detection at the expected molecular weight
Pre-absorption controls to identify non-specific binding
Multiple independent antibodies targeting different epitopes
siRNA knockdown to confirm signal reduction correlates with protein depletion
Mass spectrometry analysis of immunoprecipitated proteins
These validation approaches should be documented systematically, as they provide critical evidence for antibody specificity that reviewers often require in publications .
When encountering issues with Western blot detection of SPAC29A4.23, consider these systematic troubleshooting approaches:
Optimize antibody concentration (test serial dilutions from 1:100 to 1:5000)
Increase protein loading (20-50 μg of total protein)
Extend primary antibody incubation (overnight at 4°C)
Use more sensitive detection methods (ECL Prime or SuperSignal West Femto)
Verify extraction protocol preserves the protein of interest
Check if the epitope is masked by protein denaturation conditions
Increase blocking stringency (5% BSA or milk, 0.1% Tween-20)
Reduce primary antibody concentration
Increase wash number and duration (5-6 washes, 10 minutes each)
Filter buffers to remove particulates
Ensure membranes are fully submerged during all incubations
Determine if bands represent isoforms, degradation products, or post-translational modifications
Optimize sample preparation to reduce degradation (add protease inhibitors)
Compare with positive control samples when available
Test different lysis buffers for optimal extraction
Document all optimization steps systematically to establish reproducible protocols for future experiments .
Computational tools offer significant advantages for developing optimized antibodies:
RAbD employs a structural-bioinformatics approach to design antibodies with improved target specificity. The framework:
Samples diverse sequence and structural space of antibodies
Models antibody-antigen complexes in customizable protocols
Grafts structures from canonical clusters of complementarity-determining regions (CDRs)
Optimizes binding properties through computational prediction of interaction energy
IsAb provides a computational antibody design pipeline that:
Predicts 3D antibody structures when experimental structures are unavailable
Uses RosettaRelax to minimize energy of protein structures
Performs two-step docking (global and local) to predict binding conformations
Identifies hotspots through alanine scanning
Conducts computational affinity maturation to improve antibody properties
Researchers can leverage these tools to design improved antibodies against difficult targets or to enhance the performance of existing antibodies against SPAC29A4.23 .
Studying protein dynamics throughout the cell cycle requires careful experimental design:
Use established methods for S. pombe synchronization (nitrogen starvation, hydroxyurea block, or temperature-sensitive cdc mutants)
Collect samples at defined intervals (typically 20-30 minute intervals over 4-6 hours)
Verify synchronization efficiency using DAPI staining and FACS analysis
Quantify expression by Western blot at each time point
Normalize to appropriate loading controls (e.g., α-tubulin)
Track localization changes by immunofluorescence microscopy
Consider using time-lapse imaging for dynamic studies
Correlate protein levels/localization with cell cycle phase markers
Create quantitative profiles of protein expression throughout the cycle
Compare behavior under normal and perturbed conditions
If SPAC29A4.23 plays a role in cell wall biology, several specialized approaches can be employed:
Immunogold electron microscopy to precisely localize the protein within cell wall layers
Co-localization with known cell wall synthesis enzymes
Tracking localization during septum formation and cell division
Compare expression and localization in wild-type versus cell wall mutants
Analyze protein behavior under cell wall stress conditions (e.g., calcofluor white, Congo red)
Investigate protein dynamics during protoplast regeneration
Combine antibody studies with specific staining for cell wall components:
Aniline blue for β-1,3-glucan
Wheat germ agglutinin for chitin/chitosan
Concanavalin A for mannoproteins
Assess cell wall composition in strains with altered SPAC29A4.23 expression
This multi-faceted approach can reveal connections between SPAC29A4.23 and specific aspects of cell wall architecture or dynamics .
Identifying and characterizing post-translational modifications requires specialized techniques:
Mobility shift assays on Western blots (modified proteins often migrate differently)
Modification-specific antibodies (phospho-, glyco-, ubiquitin-specific)
Stains for glycoproteins (PAS-Silver staining as mentioned in search result 9)
EndoH treatment to detect N-glycosylation (procedure mentioned in search result 9)
Phosphopeptide enrichment (IMAC, TiO₂ chromatography)
Glycopeptide enrichment (lectin affinity, hydrazide chemistry)
Ubiquitinated protein capture (TUBE technology)
2D gel electrophoresis to separate modified isoforms
Mass spectrometry for precise identification of modifications and their sites
Targeted analysis based on motif predictions (e.g., phosphorylation motifs)
Comparison of modification patterns under different cellular conditions
For comprehensive characterization, combining multiple approaches provides the most reliable results .
Modern research benefits from integrating multiple data types:
ChIP-seq: If SPAC29A4.23 interacts with DNA or chromatin, use the antibody for chromatin immunoprecipitation followed by sequencing
RIP-seq: For RNA-binding proteins, perform RNA immunoprecipitation followed by sequencing
IP-MS: Combine immunoprecipitation with mass spectrometry to identify interaction partners
Correlate protein expression levels with corresponding gene expression (transcriptomics)
Map protein interactions to metabolic pathways (metabolomics)
Relate localization changes to chromosomal organization data (Hi-C)
Employ computational tools to integrate diverse datasets
Utilize network analysis to place SPAC29A4.23 in functional contexts
Develop predictive models based on multi-omics data
This integrative approach provides a systems-level understanding of SPAC29A4.23 function within the broader cellular context, revealing insights not attainable through single-technique approaches .
For researchers working with SPAC29A4.23 Antibody, these resources can provide valuable support:
| Resource | Description | Application |
|---|---|---|
| PomBase | S. pombe genome database with protein annotation | Gene/protein information and homology |
| UniProt (P0CU25) | Protein sequence and annotation database | Sequence information, domain structure |
| Antibody Validation Database | Repository of validation methods and results | Validation protocols and standards |
| S. pombe Community Resources | Protocols and strain repositories | Experimental methods specific to fission yeast |
| Structural Databases (PDB) | 3D protein structures | Target epitope prediction and modeling |